March 13, 2018 / 11:15 AM / 3 months ago

BRIEF-Madrigal Pharmaceuticals Qtrly ‍Loss Per Share $0.67​

March 13 (Reuters) - Madrigal Pharmaceuticals Inc:

* MADRIGAL PHARMACEUTICALS REPORTS 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS, REVIEWS KEY CORPORATE ACHIEVEMENTS AND PROVIDES CLINICAL UPDATE ON MGL-3196

* MADRIGAL PHARMACEUTICALS INC - QTRLY ‍LOSS PER SHARE $0.67​

* MADRIGAL PHARMACEUTICALS INC - CO IS IN A “STRONG” FINANCIAL POSITION TO ADVANCE MGL-3196 IN BOTH INDICATIONS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below